Merck's Vioxx shareholder suits consolidated

Class action litigation from those who have taken Vioxx are not Merck's only concern at the moment. Merck is also liable to it's shareholders, who were misled by the company they trusted and many lost thousands of dollars when the stock tumbled following the Vioxx recall. Well, today, the federal Judicial Panel of Multidistrict Litigation granted Merck & Co's motion to consolidate all pending shareholder lawsuits into one multidistrict litigation. Therefore, the cases are being transferred to a federal district court in New Jersey. More information can be found here from CBS Marketwatch.